GENOMIC INSTABILITY AND CANCER GENETICS PROGRAM PROJECT SUMMARY/ABSTRACT The Genomic Instability and Cancer Genetics (GICG) Program is organized around the central concepts that cancer results from the accumulation of genomic alterations, and that well-defined descriptions of DNA repair mechanisms, cancer genomes, and gene expression landscapes can reveal the vulnerability of cancer to interventions. The overall goal is to determine how cells maintain the integrity of their genomes, define the landscapes of cancer genomes, and facilitate identification of biomarkers and therapeutic targets. The GICG Program is composed of a highly qualified team of 44 members of diverse and complementary expertise from 19 Departments, 7 Schools, and 2 Universities. Our research is funded by a total of $11.2 million annual direct funding, including $8.6 million cancer-relevant funding ($3 million annual direct funds from NCI), 22 fully-cancer focused and NIH R01 equivalent research grants from 17 different and independent PD/PIs, and 11 multi-PI awards. Productivity and collaboration within GICG is evident from the significantly increased cancer-focused publications (586, up from 388 in 2004-2010), 30% collaborative publications (up from 25% in 2004-2010) including those that are 17% intra- and 24% inter-programmatic (up from 9.3% and 20% in 2004-2010), 54% inter-institutional collaborative publications, and 28% of the publications are in top tier journals. Achievements toward the scientific goals are exemplified by the demonstration of a distinct role of BRCA1- PALB2 interaction in supporting conserved homologous combinational DNA repair and suppressing mutagenic DNA single strand annealing, identification that the Pif1 DNA helicase overcomes replication fork blocks at G4-rich regions, mechanistic elucidation of the gain-of-function p53 mutations in the regulation of cancer metabolism and metastasis, discovery of two subtypes of oncocytomas with distinct mutational signatures, and the discovery of increased mutation burden at the nuclear peripheral lamina chromosome domains due to genome wide DNA repair heterogeneity. Translation and inter-programmatic interaction are reflected by the contribution of GICG to the genomic analysis of tumors with the application of state-of-the- art cancer genomic approaches as an integrated part of our clinical practice of Precision Medicine, new clinical trials based on the understanding of genomic instability and cancer mutation burden, and laboratory inquiries of new hypotheses emanating from the Clinical Investigations and Precision Therapeutics (CIPT) Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA072720-20
Application #
9632904
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-03-07
Budget End
2020-02-29
Support Year
20
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Rbhs -Cancer Institute of New Jersey
Department
Type
DUNS #
078728091
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Lalani, Almin I; Zhu, Sining; Xie, Ping (2018) Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay. J Vis Exp :
Warner, Wayne A; Lee, Tammy Y; Badal, Kimberly et al. (2018) Cancer incidence and mortality rates and trends in Trinidad and Tobago. BMC Cancer 18:712
Qin, Bo; Llanos, Adana A M; Lin, Yong et al. (2018) Validity of self-reported weight, height, and body mass index among African American breast cancer survivors. J Cancer Surviv 12:460-468
Farber, Nicholas J; Radadia, Kushan D; Singer, Eric A (2018) Accuracy of Nodal Staging and Outcomes of Lymphadenectomy for Non-metastatic Renal Cell Carcinoma: An Analysis of the National Cancer Database. Bladder Cancer 4:S14-S15
Poillet-Perez, Laura; Xie, Xiaoqi; Zhan, Le et al. (2018) Autophagy maintains tumour growth through circulating arginine. Nature 563:569-573
Chan, Chang S; Laddha, Saurabh V; Lewis, Peter W et al. (2018) ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup. Nat Commun 9:4158
Panda, Anshuman; de Cubas, Aguirre A; Stein, Mark et al. (2018) Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. JCI Insight 3:
Warner, Wayne A; Lee, Tammy Y; Fang, Fang et al. (2018) The burden of prostate cancer in Trinidad and Tobago: one of the highest mortality rates in the world. Cancer Causes Control 29:685-697
Zhao, Yuhan; Wu, Lihua; Yue, Xuetian et al. (2018) A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models. Elife 7:

Showing the most recent 10 out of 775 publications